California

Medi-Cal has announced that it will accept pharmacy claims for dates of service on or after April 1, 2021, that use Moderna’s new National Drug Code (NDC) when billing for the administration of either dose of the Moderna COVID-19 vaccine.  Details have been posted to the Medi-Cal News area of each provider community page on the Medi-Cal Provider website

Also in California, the Department of Health Care Services issued an All Plan Letter 20-022 (Revised) to all Medi-Cal Managed Care Health Plans regarding COVID-19 vaccine administration.   In the letter, DHCS indicates, that in addition to arranging appointments for vaccines for homebound members via My Turn, Managed Care Health Plans may also continue to schedule vaccines for homebound members that work best for this population of patients.

Also in California, Medi-Cal announced a temporary increase in COVID-19 durable medical equipment (DME) oxygen and respiratory rates.  Effective for dates of service on or after March 1, 2020, and updated effective January 1, 2021, DME oxygen and respiratory rates are temporarily increased due to the ongoing COVID-19 Public Health Emergency.

Also in California, the Global Medi-Cal DUR Board will meet via webinar on May 18, 2021.  The following information has been posted to the DUR Board Meetings page of the Medi-Cal website including the Agenda, Meeting Packet, and Registration.

Also in California, the State Board of Pharmacy elected new officers for terms beginning June 1, 2021, They include the following:  Dr. Seung Oh, President; Dr. Maria Serpa, Vice President; Jignesh “Jig” Patel, Treasurer.

Lastly in California, the State Board of Pharmacy added a teleconference Board Meeting date scheduled for May 27, 2021. The agenda will be posted on the Board’s website 10 days before the meeting.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.